1. Home
  2. EVTL vs CUE Comparison

EVTL vs CUE Comparison

Compare EVTL & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$0.74

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$31.79

Market Cap

233.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
CUE
Founded
2016
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
233.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
EVTL
CUE
Price
$0.74
$31.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$12.70
★ $120.00
AVG Volume (30 Days)
★ 5.1M
345.6K
Earning Date
03-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.11
EPS
★ N/A
N/A
Revenue
N/A
★ $27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 195.75
52 Week Low
$0.52
$0.17
52 Week High
$7.35
$45.50

Technical Indicators

Market Signals
Indicator
EVTL
CUE
Relative Strength Index (RSI) 50.83 52.87
Support Level $0.52 $23.47
Resistance Level $1.42 $33.11
Average True Range (ATR) 0.06 4.89
MACD 0.04 0.09
Stochastic Oscillator 78.50 45.37

Price Performance

Historical Comparison
EVTL
CUE

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Share on Social Networks: